PubRank

Response.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 24700799)

Published in J Natl Cancer Inst on April 03, 2014

Authors

James M Rae1, Brian Leyland-Jones2, Meredith Regan2

Author Affiliations

1: NotesAffiliations of authors: Department of Internal Medicine and Department of Pharmacology, Michigan Medical School, Ann Arbor, MI (JMR); Edith Sanford Breast Cancer Research, Sanford Health and Research, Sioux Falls, SD (BL-J); Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA (MR). jimmyrae@umich.edu.
2: NotesAffiliations of authors: Department of Internal Medicine and Department of Pharmacology, Michigan Medical School, Ann Arbor, MI (JMR); Edith Sanford Breast Cancer Research, Sanford Health and Research, Sioux Falls, SD (BL-J); Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA (MR).

Articles citing this ↘

Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity. Am J Epidemiol (2016) 0.75

Articles cited by this ↗

Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA. J Natl Cancer Inst (2013) 3.35

Re: Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA. J Natl Cancer Inst (2014) 1.45